Cytotoxicity

From WikiMD's Medical Encyclopedia

(Redirected from Cytotoxic)

Cytotoxicity

Cytotoxicity refers to the quality of being toxic to cells. It is a critical concept in the fields of pharmacology, toxicology, and oncology, as it pertains to the ability of certain substances or cells to kill or damage cells. Understanding cytotoxicity is essential for the development of new drugs, particularly in cancer treatment, where the goal is to selectively target and destroy cancerous cells while minimizing harm to normal cells.

Mechanisms of Cytotoxicity[edit]

Cytotoxicity can occur through various mechanisms, including:

  • Apoptosis: A form of programmed cell death that is often triggered by cytotoxic agents. Apoptosis is characterized by cell shrinkage, chromatin condensation, and DNA fragmentation.
  • Necrosis: A form of traumatic cell death resulting from acute cellular injury. Unlike apoptosis, necrosis often results in inflammation.
  • Autophagy: A process where cells degrade their own components through the lysosomal machinery, which can lead to cell death under certain conditions.

Cytotoxic Agents[edit]

Cytotoxic agents can be classified into several categories based on their origin and mechanism of action:

Measuring Cytotoxicity[edit]

Several assays are used to measure cytotoxicity in vitro, including:

  • MTT assay: A colorimetric assay that measures cell metabolic activity as an indicator of cell viability, proliferation, and cytotoxicity.
  • LDH release assay: Measures the release of lactate dehydrogenase from damaged cells, indicating cell membrane integrity.
  • Flow cytometry: Used to assess cell death by measuring markers such as annexin V and propidium iodide.

Clinical Applications[edit]

Cytotoxicity is a key consideration in the development of new therapeutic agents. In cancer therapy, the goal is to maximize the cytotoxic effect on cancer cells while minimizing damage to normal cells. This requires a deep understanding of the mechanisms of action of cytotoxic agents and the cellular pathways involved in cell death.

Challenges and Considerations[edit]

One of the major challenges in the use of cytotoxic agents is the development of resistance by cancer cells. This can occur through various mechanisms, such as increased drug efflux, enhanced DNA repair, and alterations in cell death pathways. Overcoming resistance is a major focus of current research in cancer therapy.

Also see[edit]


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.